Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

TSC1 mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

PTEN mutation + TSC1 mutation (1)

TSC1 1907_1908del (1)

PTEN mutation + TSC1 mutation (1)

TSC1 1907_1908del (1)

›

TSC1 mutation	Endometrial Cancer	TSC1 mutation	Endometrial Cancer	temsirolimus Sensitive: C3 – Early Trials temsirolimus Sensitive : C3	temsirolimus Sensitive: C3 – Early Trials temsirolimus Sensitive : C3
TSC1 mutation	Renal Cell Carcinoma	TSC1 mutation	Renal Cell Carcinoma	everolimus Sensitive: C3 – Early Trials everolimus Sensitive : C3	everolimus Sensitive: C3 – Early Trials everolimus Sensitive : C3
TSC1 mutation	Renal Cell Carcinoma	TSC1 mutation	Renal Cell Carcinoma	temsirolimus Sensitive: C3 – Early Trials temsirolimus Sensitive : C3	temsirolimus Sensitive: C3 – Early Trials temsirolimus Sensitive : C3
TSC1 mutation	Bladder Cancer	TSC1 mutation	Bladder Cancer	everolimus Sensitive: C3 – Early Trials everolimus Sensitive : C3	everolimus Sensitive: C3 – Early Trials everolimus Sensitive : C3
TSC1 mutation	Renal Cell Carcinoma	TSC1 mutation	Renal Cell Carcinoma	mTOR inhibitor Sensitive: C3 – Early Trials mTOR inhibitor Sensitive : C3	mTOR inhibitor Sensitive: C3 – Early Trials mTOR inhibitor Sensitive : C3
TSC1 mutation	Hepatocellular Cancer	TSC1 mutation	Hepatocellular Cancer	everolimus Sensitive: C4 – Case Studies everolimus Sensitive : C4	everolimus Sensitive: C4 – Case Studies everolimus Sensitive : C4